The v-erbA oncogene codes for a mutated form of the thyroid hormone re
ceptor TRlc-eubA-alpha, Thyroid hormone (triiodothyronine, T3) regulat
es glial functions such as myelination and both astrocytes and oligode
ndrocytes have been shown to express thyroid hormone receptors (TRs).
To study putative effects of v-erbA on glial precursors, we have expre
ssed it in a glial clonal cell line established from early embryonal m
ouse brain, We have found that v-erbA increases cell survival in serum
-free conditions. Moreover, v-erbA-expressing cells show a substantial
growth in the presence of insulin or IGF-I, whereas normal and TR/c-e
rbA-over-expressing cells progressively degenerate. By Northern blotti
ng, immuno-fluorescence, immunoprecipitation, and neutralization exper
iments, we show that v-erbA actions are mediated by an increase in the
levels of PDGF B/c-sis mRNA and protein. We used anti-PDGF receptor a
nd antiphosphotyrosine antibodies to show the constitutive activation
of PDGF receptors in B3.1+v-erbA cells, and neutralizing anti-PDGF ant
ibodies to demonstrate that v-erbA enhances the secretion of active PD
GF into the culture medium. Our data indicate that v-erbA induces PDGF
B/c-sis, a factor involved in the generation df gliomas, the most com
mon central nervous system tumor in humans.